Cancer cells can hide from the immune system to continue growing and spreading.
Is it true that cancer cells can hide from the immune system to continue growing and spreading?
Yes. Extensive oncological research demonstrates that cancer cells employ diverse strategies—such as altering antigen presentation, modifying the tumor microenvironment, and co-opting metabolic and signaling pathways—to evade the immune system and drive tumor progression.
Verdict: SUPPORTED · 10 sources for, 0 against · Last checked
The claim is a specific, well-established biological reality in oncology. All retrieved papers thoroughly support the premise that cancer cells utilize various mechanisms to hide from or suppress the immune system, enabling continued growth and spreading.
Get citation
Ruan, L. & Wang, L. (2025). Adoptive cell therapy against tumor immune evasion: mechanisms, innovations, and future directions. doi.org. https://doi.org/10.3389/fonc.2025.1530541
See more details
Get citation
L, C., Y, W., Q, H., Y, L., X, Q., Z, T., H, H., N, L., S, Z., & L, Y. (2023). Unveiling tumor immune evasion mechanisms: abnormal expression of transporters on immune cells in the tumor microenvironment.. doi.org. https://doi.org/10.3389/fimmu.2023.1225948
Get citation
Q, W. & K, T. (2022). Immunoregulatory signal networks and tumor immune evasion mechanisms: insights into therapeutic targets and agents in clinical development.. doi.org. https://doi.org/10.1042/bcj20210233
Get citation
R, L., W, S., Z, W., H, W., C, L., L, Y., & R, G. (2025). Unveiling mitochondrial transfer in tumor immune evasion: mechanisms, challenges, and clinical implications.. doi.org. https://doi.org/10.3389/fimmu.2025.1625814
Get citation
Y, M., W, D., X, J., & Y, Z. (2026). RNA epitranscriptomic regulation of tumor immune evasion: mechanisms, context-dependent roles, and therapeutic implications.. doi.org. https://doi.org/10.3389/fimmu.2026.1857099
Get citation
J, L. & G, L. (2026). Mitophagy-driven immune evasion in skin cancer: multidimensional regulatory networks and context-dependent therapeutic strategies-a narrative review.. doi.org. https://doi.org/10.3389/fimmu.2026.1949371
Get citation
R, P. & EF, L. (2026). Targeting the Epigenetic-Immune Axes in Hematologic Malignancies.. doi.org. https://doi.org/10.3390/cancers18182985
Get citation
W, C. (2026). IGF2BP3-Mediated m6A Modification of OLR1 mRNA Promotes Immune Evasion in CRC via the PI3K/AKT/mTOR Pathway.. doi.org. https://doi.org/10.1097/cji.0000000000000613
Get citation
Hernández, J. L. G. & Smith, J. (2025). Tumor Microenvironment and Immune Evasion Mechanisms. doi.org. https://doi.org/10.70996/cip.00005
Get citation
LI, M. (2025). Tumor Immune Evasion Mechanisms and Immunotherapy Strategies. doi.org. https://doi.org/10.54254/2753-8818/2025.au27725
What does the evidence say?
The claim is a specific, well-established biological reality in oncology. All retrieved papers thoroughly support the premise that cancer cells utilize various mechanisms to hide from or suppress the immune system, enabling continued growth and spreading.
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work